May 30, 2017
May 30, 2017

Stretta Presentations and New Data at DDW 2017 Highlight Positive Outcomes

Mederi Therapeutics announced highlights of educational activities on Stretta Therapy for Gastroesophageal Reflux Disease (GERD) that took place at Digestive Disease Week® 2017 (DDW 2017). The activities included a presentation on "Unmet Needs in GERD Treatment", presented by Dr. Ronnie Fass and Professor Jan Tack. The presentation featured data from the new Stretta Meta-Analysis as well as data on mechanism and GERD outcome measures.
Do you like it?
Read more
April 25, 2017
April 25, 2017

Stretta Presentation DDW2017 – Unmet Needs in GERD Treatment

Please join us on Monday May 8 from 1:30-2:30 pm in the ASGE Learning Center at DDW2017 for a special presentation! Dr. Ronnie Fass and Professor Jan Tack will present on the Unmet Needs in GERD Treatment - and why you should consider Stretta in your clinical practice. These worldwide leaders in GERD will review the recently published Meta-Analysis on Stretta as well as other data on long-term outcomes and mechanism of action.
Do you like it?
Read more
June 13, 2016
June 13, 2016

New Study: Stretta Treatment of GERD Can Yield Meaningful Cost Savings For Payers

Mederi Therapeutics, Inc., manufacturers of Stretta Therapy for GERD, today announced that a new study, published in Managed Care, suggests the potential for substantial payer cost savings associated with radiofrequency energy (RFE) treatment of GERD patients, as compared to treatment with medical management or fundoplication.
Do you like it?
Read more
June 13, 2016
June 13, 2016

New Stretta Data Shows 10-yr Effectiveness in Challenging GERD Patients

Stretta clinical data presented at DDW2016 shows effectiveness in challenging GERD patient populations: Obese patients, laryngopharyngeal reflux (LPR) symptoms, GERD post-nissen. DDW activities also included the launch of the new Stretta RFT3 system and four presentations by international Stretta expert physicians.
Do you like it?
Read more
January 28, 2016
January 28, 2016

New Study Confirms Stretta Therapy for GERD to be Safe, Effective and Durable

Stretta Therapy, a non-ablative radiofrequency treatment for GERD, was called "effective, safe and durable following 15 years of worldwide use" and cited as a "viable complement or alternative to medical and surgical treatment" in a newly-published clinical review of endoscopic techniques for gastroesophageal reflux disease (GERD). Authors Wai-Kit Lo, MD, MPH and Hiroshi Mashimo, MD, PhD of Harvard Medical School, examined multiple alternatives to PPI therapy or surgery, including Stretta and other devices such as endoscopic plication and suturing, as well as injectable and implantable bulking agents. Their findings have been published in the Journal of Clinical Gastroenterology.
Do you like it?
Read more
November 25, 2015
November 25, 2015

Survey Confirms Holiday Season Marks Higher Incidence Of Reflux Complaints

GERD Awareness Week reinforces the need for patient education and encourages those suffering to determine whether their reflux is diet related or is a chronic condition, as well as to explore treatment options. The results of a survey of U.S. gastroenterologists revealed that physicians see more patients complaining of reflux during the holidays. Appropriately, GERD Awareness Week 2015 kicks off the holiday season, Thanksgiving week – November 22-28.
Do you like it?
Read more
November 18, 2015
November 18, 2015

Fall Congresses Focus on Stretta Therapy as a Versatile Option for Chronic GERD

Major medical congresses this fall showcased the role of Stretta in the treatment of gastroesophageal reflux disease (GERD). Sessions featuring Stretta were part of the educational programs at Obesity Week, the International Federation for Surgery of Obesity (IFSO), American College of Surgeons (ACS), and the World Organization for Specialized Studies on Diseases of the Esophagus (OESO).
Do you like it?
Read more